Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Shanghai JMT-Bio Inc.
Enrollment target
~286 participants
Primary completion
November 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2023